Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-Sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin

NCT03997370 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT03997370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03997370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-Sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin
Lead sponsor
NRG Oncology
Phase
Phase 1
Overall status
Active, not recruiting
Start date
January 15, 2020
Completion date
March 14, 2028
Enrollment
350 (estimated)
Sites
189

Conditions

As the registry lists them; a condition with its own page is linked.

malignant solid neoplasm